A UK-Based Cost-Utility Analysis of Indacaterol, A Once-Daily Maintenance Bronchodilator for Patients with COPD, Using Real World Evidence on Resource Use

INTRODUCTION: Chronic Obstructive Pulmonary Disease (COPD) is a chronic, progressive disease that is not curable. However, there are effective treatments available. In the UK, long-acting bronchodilators are first-line treatments for COPD patients requiring maintenance therapy, and there are several...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, David, Asukai, Yumi, Ananthapavan, Jaithri, Malcolm, Bill, Radwan, Amr, Keyzor, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663982/
https://www.ncbi.nlm.nih.gov/pubmed/23529714
http://dx.doi.org/10.1007/s40258-013-0021-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663982/
https://www.ncbi.nlm.nih.gov/pubmed/23529714
http://dx.doi.org/10.1007/s40258-013-0021-5

Ejemplares similares